|
2022
|
Invention
|
Novel galactoside inhibitor of galectins. The present invention relates to a is β-D-galactopyrano... |
|
|
Invention
|
Galactoside inhibitor of galectins. A compound of the general formula (1). The compound of formul... |
|
|
Invention
|
Galactoside inhibitor of galectins. An embodiment of the present invention relates to a compound ... |
|
|
Invention
|
Once-daily treatment of pulmonary fibrosis.
A compound of formula (I) for use in a method for tr... |
|
|
Invention
|
D-galactopyranoside derivatives as inhibitors of galectin. The present invention relates to beta ... |
|
|
Invention
|
Novel galactoside inhibitor of galectins. The present invention relates to a D-galactopyranose co... |
|
2021
|
Invention
|
Novel galactoside inhibitor of galectins.
A D-galactopyranose compound of formula (1)
A D-gala... |
|
|
Invention
|
Novel galactoside inhibitor of galectins.
D-galactopyranose compound of formula (1)
D-galactop... |
|
|
Invention
|
Galactoside inhibitor of galectins. An α-D-galactopyranose compound of the general formula (1). T... |
|
|
Invention
|
Idiopathic pulmonary fibrosis-detection, monitoring, prediction methods.
Provided is a compound ... |
|
|
Invention
|
Large scale process for preparing 1,2,4, 6-tetra-o-acetyl-3-azido-3-deoxy-d-galactopyranoside.
A... |
|
|
Invention
|
Large scale process for preparing 1,2,4, 6-tetra-0-acetyl-3-azid0-3-de0xy-d-galact0pyran0side. Th... |
|
2020
|
Invention
|
Large scale process.
A process for preparing a compound of formula (I)
A process for preparing... |
|
|
Invention
|
Large scale process for the preparation of 5-bromopyridin-3-yl-3-deoxy-3-[4-(3,4,5-trifluoropheny... |
|
|
P/S
|
Pharmaceutical, medical and veterinary medicinal products for treatment of cancer, fibrotic disea... |
|
|
Invention
|
Novel galactoside inhibitor of galectins.
The present invention relates to a D-galactopyranose c... |
|
|
Invention
|
Large scale process of 3,3'-dideoxy-3,3'-bis-[4-(3-fluorophenyl)-1h-1,2,3-triazol-1-yl]-1,1'-sulf... |
|
2019
|
Invention
|
Amorphous form of 5-bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1h-1,2,3-triazol-1-yl]... |
|
|
Invention
|
Amorphous form and process. The present invention relates to a stabilized amorphous form of a com... |
|
|
Invention
|
Alpha-d-galactoside inhibitors of galectins. The present invention relates to a compound of the g... |
|
|
Invention
|
Prodrug galactoside inhibitor of galectins.
A prodrug compound of the general formula I or II. T... |
|
|
Invention
|
Galactoside inhibitor of galectins.
A compound of the general formula I or II. The compound of f... |
|
|
Invention
|
Galactoside inhibitor of galectins. The present invention relates to a compound of the general fo... |
|
|
Invention
|
Prodrug of galactoside inhibitors of galectins. The present invention relates to a prodrug compou... |
